Home 📚BioDBS Bibliography database[Title] Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database

Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database

database[Title] 2024-04-24

Summary:

CONCLUSION: Among T2N1M0 stage HR + /HER2- patients, OS and BCSS of NACT were inferior to ACT. Patients who attained non-pCR after NACT demonstrated significantly worse survival outcomes compared with those who received ACT.

Link:

https://pubmed.ncbi.nlm.nih.gov/38643430/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20240424165644&v=2.18.0.post9+e462414

From feeds:

📚BioDBS Bibliography » database[Title]

Tags:

Authors:

Yuhang Shang, Xuelian Wang, Yansong Liu, Weilun Cheng, Yunqiang Duan, Zhengbo Fang, Jiangwei Liu, Fanjing Kong, Ting Wang, Tianshui Yu, Anbang Hu, Jiarui Zhang, Hanyu Zhang, Mingcui Li, Zhiyuan Rong, Yanling Li, Suborna S Shakila, Xinxin Li, Jianyuan Feng, Fei Ma, Baoliang Guo

Date tagged:

04/24/2024, 16:59

Date published:

04/21/2024, 06:00